Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **lung parenchymal tissue** comprises the portion of the lung involved in gas exchange, mainly consisting of alveoli, alveolar ducts, and respiratory bronchioles. Unlike airways or vasculature, parenchymal tissue is defined by its histological and functional role rather than a specific molecular entity. Its primary function is to facilitate oxygen and carbon dioxide exchange between air and blood[3][2]. The **mechanical properties** of lung parenchyma arise from the composition and organization of collagen and elastic fibers in the extracellular matrix, which determine lung elasticity, resistance, and recoil[1]. Diseases such as fibrosis, emphysema, and inflammation alter the structure and mechanics of lung parenchyma, leading to impaired respiratory function[1]. Drug therapies in respiratory disease may affect cells within parenchymal tissue but do not target the parenchyma directly as a molecular entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lung parenchymal tissue.